These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6167672)

  • 1. Neuropeptides in striato-nigral pathways.
    Cuello AC; Del Fiacco M; Paxinos G; Somogyi P; Priestley JV
    J Neural Transm; 1981; 51(1-2):83-96. PubMed ID: 6167672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.
    Christensson-Nylander I; Herrera-Marschitz M; Staines W; Hökfelt T; Terenius L; Ungerstedt U; Cuello C; Oertel WH; Goldstein M
    Exp Brain Res; 1986; 64(1):169-92. PubMed ID: 2429858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis.
    Herrera-Marschitz M; Christensson-Nylander I; Sharp T; Staines W; Reid M; Hökfelt T; Terenius L; Ungerstedt U
    Exp Brain Res; 1986; 64(1):193-207. PubMed ID: 2429859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine receptors mediate alterations in striato-nigral dynorphin and substance P pathways.
    Nylander I; Terenius LH
    Neuropharmacology; 1987 Sep; 26(9):1295-302. PubMed ID: 2444900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo release of newly synthesized [3H]GABA in the substantia nigra of the rat: relative contribution of GABA striato-pallido-nigral afferents and nigral GABA neurons.
    Lantin le Boulch N; Truong-Ngoc NA; Gauchy C; Besson MJ
    Brain Res; 1991 Sep; 559(2):200-10. PubMed ID: 1794098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: a biochemical and immunohistochemical study.
    Jessell TM; Emson PC; Paxinos G; Cuello AC
    Brain Res; 1978 Sep; 152(3):487-98. PubMed ID: 356929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of suicide transport lesions of the striatonigral or striatopallidal pathways on subsets of striatal neurons.
    Roberts RC; Harrison MB; Francis SM; Wiley RG
    Exp Neurol; 1993 Dec; 124(2):242-52. PubMed ID: 7507060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of striato-nigral substance P in the regulation of the activity of the nigro-striatal dopaminergic neurons.
    Glowinski J; Michelot R; Chéramy A
    Adv Biochem Psychopharmacol; 1980; 22():51-62. PubMed ID: 6156583
    [No Abstract]   [Full Text] [Related]  

  • 9. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
    Paladini CA; Celada P; Tepper JM
    Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.
    Marshall PE; Landis DM; Zalneraitis EL
    Brain Res; 1983 Dec; 289(1-2):11-26. PubMed ID: 6198034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for substance P in the striato-nigral tract.
    Mroz EA; Brownstein MJ; Leeman SE
    Brain Res; 1977 Apr; 125(2):305-11. PubMed ID: 856411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neostriatal enkephalin-immunoreactive neurones project to the globus pallidus.
    Del Fiacco M; Paxinos G; Cuello AC
    Brain Res; 1982 Jan; 231(1):1-17. PubMed ID: 6275943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of substance P and enkephalin immunoreactivity in the human substantia nigra after striato-pallidal infarction.
    Pioro EP; Hughes JT; Cuello AC
    Brain Res; 1984 Feb; 292(2):339-47. PubMed ID: 6198046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic striatal kainate lesions on some dopaminergic parameters and enkephalin immunoreactive neurons in the basal ganglia.
    Schwarcz R; Fuxe K; Hökfelt T; Terenius L; Goldstein M
    J Neurochem; 1980 Apr; 34(4):772-8. PubMed ID: 6102111
    [No Abstract]   [Full Text] [Related]  

  • 15. On the location of methionine enkephalin neurons in rat striatum.
    Hong JS; Yang HY; Costa E
    Neuropharmacology; 1977 Jun; 16(6):451-3. PubMed ID: 20590
    [No Abstract]   [Full Text] [Related]  

  • 16. The distribution of dynorphinergic terminals in striatal target regions in comparison to the distribution of substance P-containing and enkephalinergic terminals in monkeys and humans.
    Reiner A; Medina L; Haber SN
    Neuroscience; 1999; 88(3):775-93. PubMed ID: 10363817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotransmitters contained in the efferents of the striatum.
    Staines WA; Nagy JI; Vincent SR; Fibiger HC
    Brain Res; 1980 Aug; 194(2):391-402. PubMed ID: 6155976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of girisopam (a 2,3-benzodiazepine derivative) to the substantia nigra is prevented by lesioning of the striatonigral pathway.
    Palkovits M; Lovas G; Horváth E
    Neuroscience; 1998 Apr; 83(3):799-806. PubMed ID: 9483563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convergence of synaptic terminals from the striatum and the globus pallidus onto single neurones in the substantia nigra and the entopeduncular nucleus.
    Bolam JP; Smith Y; Ingham CA; von Krosigk M; Smith AD
    Prog Brain Res; 1993; 99():73-88. PubMed ID: 7509081
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of discrete kainic acid-induced lesions of corpus caudatus and globus pallidus on glutamic acid decarboxylase of rat substantia nigra.
    Di Chiara G; Morelli M; Porceddu ML; Mulas M; Del Fiacco M
    Brain Res; 1980 May; 189(1):193-208. PubMed ID: 7363085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.